Immunogenicity of Proteins Used as Therapeutics

Susan Richards, Amy Rosenberg, Zuben E. Sauna, Bernard Maillere, Elizabeth C. Jury — 2020

Topic Editor Susan Richards is an employee of Sanofi and owns stock in the corporation. Topic Editor Bernard Maillere declares economic support from pharmaceutical companies (Novartis, Sanofi, and UCB) in the frame of collaborations aiming to evaluate the recognition by human T cells of therapeutic proteins and antibodies.